Standard BioTools Inc.LABNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+74.7%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+74.7%/yr
vs +60.3%/yr prior
Acceleration
+14.5pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
5.3x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 155.59% |
| Q3 2025 | -3.67% |
| Q2 2025 | -28.53% |
| Q1 2025 | 23.59% |
| Q4 2024 | -26.48% |
| Q3 2024 | 41.08% |
| Q2 2024 | -42.17% |
| Q1 2024 | -62.61% |
| Q4 2023 | 5.82% |
| Q3 2023 | -23.22% |
| Q2 2023 | -1.17% |
| Q1 2023 | 19.20% |
| Q4 2022 | 29.16% |
| Q3 2022 | 53.69% |
| Q2 2022 | 16.71% |
| Q1 2022 | -709.08% |
| Q4 2021 | 31.89% |
| Q3 2021 | 19.25% |
| Q2 2021 | 8.92% |
| Q1 2021 | -4.41% |
| Q4 2020 | -200.48% |
| Q3 2020 | 53.91% |
| Q2 2020 | 18.55% |
| Q1 2020 | -25.98% |
| Q4 2019 | 1.57% |
| Q3 2019 | 6.30% |
| Q2 2019 | 45.99% |
| Q1 2019 | -72.35% |
| Q4 2018 | -0.17% |
| Q3 2018 | 9.18% |
| Q2 2018 | -22.60% |
| Q1 2018 | -26.69% |
| Q4 2017 | 34.42% |
| Q3 2017 | 5.84% |
| Q2 2017 | 1.56% |
| Q1 2017 | 2.80% |
| Q4 2016 | 10.57% |
| Q3 2016 | -6.30% |
| Q2 2016 | 6.37% |
| Q1 2016 | -54.39% |